XML 33 R22.htm IDEA: XBRL DOCUMENT v3.22.0.1
Restatement of Financial Statements (Tables)
12 Months Ended
Dec. 31, 2020
Condensed Financial Information Disclosure [Abstract]  
Schedule of impact of the restatement
   As Previously
Reported
   Adjustments   As Restated 
Audited Balance Sheet at December 23, 2020            
Warrant Liabilities  $-   $574,676   $574,676 
Total Liabilities   -    574,676    574,676 
Shares Subject to Possible Redemption   135,094,307    4,285,693    139,380,000 
Common Stock   479    (42)   437 
Additional paid-in capital   5,007,859    (4,860,327)   147,532 
Total Stockholders’ Equity   5,000,008    (4,860,369)   139,639 
                
Audited Balance Sheet at December 31, 2020               
Warrant Liabilities  $-   $580,860   $580,860 
Total Liabilities   303,738    580,860    884,598 
Shares Subject to Possible Redemption   134,983,359    4,399,888    139,383,247 
Common Stock   480    (43)   437 
Additional paid-in capital   5,118,821    (4,974,521)   144,300 
Accumulated Deficit   (119,298)   (6,184)   (125,482)
Total Stockholders’ Equity   5,000,003    (4,980,748)   19,255 
                
Audited Statement of Operations for the year ended December 31, 2020               
Change in Fair Value of Warrants  $-   $(6,184)  $(6,184)
Weighted average shares outstanding, basic and diluted   4,198,081    (4,198,081)   - 
Basic and diluted weighted average shares outstanding, common stock subject to redemption   -    339,344    339,344 
Basic and diluted weighted average shares outstanding, common stock not subject to redemption   -    3,429,593    3,429,593 
Basic and diluted net income (loss) per share   (0.03)   0.03    - 
Basic and diluted net income (loss) per share, common stock subject to redemption   -    52.43    52.43 
Basic and diluted net income (loss) per share, common stock not subject to redemption   -    (5.22)   (5.22)
                
Audited Statement of Changes in Stockholders’ Equity for the year ended December, 2020               
Issuance of Representative Shares on November 25, 2020 - Additional Paid-in-Capital  $-   $792,428   $792,428 
Issuance of Representative Shares on November 25, 2020 - Stockholders' Equity (Deficit)   15    792,428    792,443 
Initial Value of Private Warrants   -    (574,676)   (574,676)
Reclassification of offering costs related to public shares   -    3,655,046    3,655,046 
Other Offering Expenses   (532,623)   (792,428)   (1,325,051)
Net Loss   (155,543)   (6,184)   (121,727)
Maximum number of redeemable shares - Shares   (13,364,689)   (435,311)   (13,800,000)
Maximum number of redeemable shares - Par Value   (1,336)   (44)   (1,380)
Maximum number of redeemable shares - Paid-in-Capital   (134,982,023)   11,510,162    (123,471,861)
Maximum number of redeemable shares - Stockholders' Equity (Deficit)   (134,983,359)   11,510,118    (123,473,241)
Subsequent measurement of common stock subject to redemption under ASC 480-10-S99 against APIC   -    (19,561,805)   (19,561,805)
Subsequent measurement of common stock subject to redemption under ASC 480-10-S99 against APIC (interest earned on trust account)   -    (3,247)   (3,247)
                
Audited Statement of Cash Flows for the year ended December 31, 2020               
Net Loss  $(115,543)  $(6,184)  $(121,727)
Change in fair value of warrant liabilities   -    6,184    6,184 
Initial value of warrant liabilities   -    574,676    574,676 
Initial value of common stock subject to possible redemption   135,094,307    (11,621,066)   123,473,241 
Reclassification of offering costs related to public shares   -    (3,655,046)   (3,655,046)
Change in value of common stock subject to possible redemption   (110,948)   110,948    - 
Subsequent measurement of common stock subject to redemption under ASC 480-10-S99 against APIC   -    19,561,805    19,561,805 
Subsequent measurement of common stock subject to redemption under ASC 480-10-S99 against APIC (interest earned on trust account)   -    3,247    3,247